Development and validation of a novel prognostic score to predict survival in patients with metastatic colorectal cancer: the metastatic colorectal cancer score (mCCS).

Norbert MarschnerM FrankW VachE LaddaA KarcherS WinterM JänickeT Trarbach

Published in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2019)

The novel prognostic score, mCCS, clearly defines three prognostic groups for OS at start of first-line therapy. For oncologists, the mCCS represents a simple and easy-to-apply tool for routine clinical use, as it is based on objective tumour characteristics and can assist with treatment decision-making and communication of the prognosis to patients.

Keyphrases

metastatic colorectal cancer
end stage renal disease
decision making
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
clinical practice
patient reported outcomes
smoking cessation